Department of Pharmaceutics and Drug Delivery, The University of Mississippi, University, MS, 38677, USA.
Institute for Drug Delivery and Biomedical Research, Bangalore, Karnataka, India.
AAPS PharmSciTech. 2018 Jan;19(1):48-59. doi: 10.1208/s12249-017-0869-z. Epub 2017 Sep 13.
Photodegradation is one of the major pathways of the degradation of drugs. Some therapeutic agents and excipients are highly sensitive to light and undergo significant degradation, challenging the quality and the stability of the final product. The adequate knowledge of photodegradation mechanisms and kinetics of photosensitive therapeutic entities or excipients is a pivotal aspect in the product development phase. Hence, various pharmaceutical regulatory agencies, across the world, mandated the industries to assess the photodegradation of pharmaceutical products from manufacturing stage till storage, as per the guidelines given in the International Conference on Harmonization (ICH). Recently, numerous formulation and/or manufacturing strategies has been investigated for preventing the photodegradation and enhancing the photostability of photolabile components in the pharmaceutical dosage forms. The primary focus of this review is to discuss various photodegradation mechanisms, rate kinetics, and the factors that influence the rate of photodegradation. We also discuss light-induced degradation of photosensitive lipids and polymers. We conclude with a brief note on different approaches to improve the photostability of photosensitive products.
光降解是药物降解的主要途径之一。一些治疗剂和赋形剂对光高度敏感,会发生显著降解,这对最终产品的质量和稳定性构成挑战。充分了解光敏感治疗实体或赋形剂的光降解机制和动力学是产品开发阶段的关键方面。因此,世界上各种药品监管机构都要求企业按照国际人用药品注册技术协调会(ICH)给出的指导原则,评估从制造阶段到储存阶段的药品的光降解情况。最近,人们研究了许多制剂和/或制造策略,以防止光不稳定成分在药物剂型中的光降解并提高其光稳定性。本篇综述的主要重点是讨论各种光降解机制、速率动力学以及影响光降解速率的因素。我们还讨论了光敏感脂质和聚合物的光诱导降解。最后,我们简要介绍了提高光敏感产品光稳定性的不同方法。